Concepts (60)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 6 | 2016 | 688 | 0.830 |
Why?
|
| Carcinoma, Pancreatic Ductal | 4 | 2016 | 154 | 0.580 |
Why?
|
| Pancreatic Cyst | 1 | 2012 | 30 | 0.400 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 1103 | 0.260 |
Why?
|
| MicroRNAs | 1 | 2012 | 836 | 0.250 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 1414 | 0.240 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 1582 | 0.200 |
Why?
|
| Lumican | 2 | 2016 | 4 | 0.170 |
Why?
|
| Pancreatic Stellate Cells | 1 | 2016 | 7 | 0.140 |
Why?
|
| Keratan Sulfate | 1 | 2014 | 7 | 0.120 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2014 | 28 | 0.120 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 217 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 460 | 0.110 |
Why?
|
| Cell Culture Techniques | 1 | 2014 | 288 | 0.110 |
Why?
|
| Pancreatectomy | 1 | 2012 | 135 | 0.100 |
Why?
|
| Reoperation | 1 | 2012 | 808 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2012 | 1463 | 0.080 |
Why?
|
| Phenotype | 1 | 2014 | 4200 | 0.060 |
Why?
|
| Heterografts | 2 | 2016 | 183 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 6275 | 0.050 |
Why?
|
| Young Adult | 1 | 2012 | 8675 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2014 | 2321 | 0.040 |
Why?
|
| Humans | 6 | 2016 | 121798 | 0.040 |
Why?
|
| Middle Aged | 2 | 2012 | 25515 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2014 | 70 | 0.030 |
Why?
|
| Extracellular Space | 1 | 2014 | 89 | 0.030 |
Why?
|
| Deoxycytidine | 1 | 2014 | 77 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2014 | 139 | 0.030 |
Why?
|
| Aged | 1 | 2012 | 18732 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2014 | 101 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 99 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2012 | 15794 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2014 | 91 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2014 | 229 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 369 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2014 | 281 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 1073 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 602 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 535 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2014 | 1105 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2014 | 619 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 492 | 0.020 |
Why?
|
| Adult | 1 | 2012 | 28548 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2014 | 879 | 0.020 |
Why?
|
| Proteomics | 1 | 2014 | 476 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1710 | 0.020 |
Why?
|
| Male | 2 | 2012 | 59250 | 0.020 |
Why?
|
| Animals | 3 | 2016 | 33878 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 1590 | 0.020 |
Why?
|
| Female | 2 | 2012 | 64574 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 1227 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 1881 | 0.020 |
Why?
|
| Mice | 2 | 2016 | 17632 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 1205 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 1791 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 3297 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 4437 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 4306 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 4518 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2012 | 5960 | 0.010 |
Why?
|